Invasion complex and methods of targeting
CA 2454419 A1 · Owner: Children'S Medical Center Corporation · Inventors: Ashkar, Samy
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Therapeutics have been identified and developed with are targeted to inhibiting metastasis. These are based on the discovery of an invasion complex which confers the ability of cells, for example tumor cells to translocate , across extracellular matrix barriers as well as the identification of novel peptides that interact with the invasion complex and regulate it's activity. Whole or partials complexes, or individual molecules of the invasion complex are used to screen for proteins or compounds that interact with the invasion complex. Methods of screening for interacting proteins such as osteopontin sophin B (SEQ ID NO:1), or compounds are well known in the art some of which , are …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed July 18, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended July 18, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by July 18, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.